04:41 AM EDT, 10/31/2025 (MT Newswires) -- Corbus Pharmaceuticals ( CRBP ) said Friday it priced a $75 million offering of roughly 4.7 million shares at $13 apiece, as well as pre-funded warrants.

The pre-funded warrants to purchase about 1 million shares were priced at $12.9999 apiece, the company said.

Corbus intends to use the net proceeds to, among other things, fund pipeline clinical development. It granted underwriters a 30-day option to purchase up to an additional 865,384 shares.

The offering will likely close on or about Nov. 3.

Corbus shares were down 18% in premarket activity.